Commercial Labs | Fabric Genomics

Implement revenue-generating NGS testing services

Launch profitable NGS tests quickly with Fabric Genomics' streamlined interpretation platform and clinical services

NGS testing is a revenue-generating opportunity

Growth in Testing BRCA 1/2 HBOC CRC
2016-2019
718%
138%
1400%

CRC = colorectal cancer

HBOC = hereditary breast and ovarian cancer

Reimbursement amount in dollars

*Xifin reimbursement data October 2020, excluding denials

Contracted and non-contracted

CMS published rates provided for reference

Fabric's scalable NGS analysis platform
enables profitable panel testing

Customizable panels for any applications

Rapid, accurate interpretation is key

BRCA1 & BRCA2

Hereditary Breast & Ovarian Cancer

Lynch Syndrome

Hereditary Colon Cancer, Extended

Solid Tumor

Arrythmia

Cardiomyopathy

Familial Hypercholestolemia

Long QT Syndrome

Marfan, Aneurysm, & Aortopathies

Non-syndromic Epilepsies

Carrier Screening

Newborn Screening

Diagnostic Odyssey

NICU/PICU

CDC Tier01

ACMG Secondary

  • Sequence to report in minutes
  • Seamlessly integrates with LIMS and other systems
  • Fully automated variant classification cuts review time
  • Single, scalable platform for any NGS test
  • ISO 27001 certified, HIPAA and CLIA compliance programs

Getting started is simple

Step 1

Our implementation team will help you finalize your test launch plan

Step 2

We set up Fabric Enterprise for your lab including clinical workflows

Step 3

Collect samples
and sequence

Step 4

Fully automated interpretation
delivers reports in minutes

Step 5

Our team of clinical experts assists in finalizing interpretation and drafting reports, as needed

Learn how to quickly launch a profitable NGS panel test

Our team of clinical experts supports you at every step

• Comprehensive Fabric Enterprise installation
• Customized gene panels
• Configuration of clinical interpretation workflows (SOPs)
• Interpretation of panels, exomes, genomes at scale
• Clinical Services interpretation and sign out
• Lean on our network of ABMGG board-certified & board eligible medical genetics, and variant scientists

hereditary cancer treating

See how we can help you launch hereditary cancer testing

Don't miss out on rapidly growing reimbursement for NGS tests

Learn how to get started and scale up today

Ready to
get started?